162 related articles for article (PubMed ID: 7753862)
21. Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide.
Wood KS; Buga GM; Byrns RE; Ignarro LJ
Biochem Biophys Res Commun; 1990 Jul; 170(1):80-8. PubMed ID: 2164813
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
[TBL] [Abstract][Full Text] [Related]
23. Production of an arginine-derived relaxing factor induced by IFN-gamma plus endotoxin in murine adenocarcinoma EMT 6 cells.
Petit JF; Schott C; Lepoivre M; Stoclet JC
Biochem Biophys Res Commun; 1990 Nov; 173(1):1-5. PubMed ID: 2124106
[TBL] [Abstract][Full Text] [Related]
24. Divergent effects of vitamin C on relaxations of rabbit aortic rings to acetylcholine and NO-donors.
de Saram K; McNeill KL; Khokher S; Ritter JM; Chowienczyk PJ
Br J Pharmacol; 2002 Feb; 135(4):1044-50. PubMed ID: 11861333
[TBL] [Abstract][Full Text] [Related]
25. An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus.
Gibson A; Babbedge R; Brave SR; Hart SL; Hobbs AJ; Tucker JF; Wallace P; Moore PK
Br J Pharmacol; 1992 Nov; 107(3):715-21. PubMed ID: 1472969
[TBL] [Abstract][Full Text] [Related]
26. Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats.
Sunano S; Watanabe H; Tanaka S; Sekiguchi F; Shimamura K
Br J Pharmacol; 1999 Feb; 126(3):709-16. PubMed ID: 10188983
[TBL] [Abstract][Full Text] [Related]
27. NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein.
Gold ME; Wood KS; Byrns RE; Fukuto J; Ignarro LJ
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4430-4. PubMed ID: 2162040
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
[TBL] [Abstract][Full Text] [Related]
29. Role of endothelium-derived relaxing factor on vascular reactivity in endotoxin-induced shock.
Yen MH; Chen SJ; Wu CC
Chin J Physiol; 1993; 36(4):225-31. PubMed ID: 8020337
[TBL] [Abstract][Full Text] [Related]
30. Sex differences in nitric oxide-mediated attenuation of vascular reactivity to vasopressin are abolished by gonadectomy.
Stallone JN
Eur J Pharmacol; 1994 Jul; 259(3):273-83. PubMed ID: 7982454
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta 1 inhibits L-arginine-derived relaxing factor(s) from smooth muscle cells.
Junquero DC; Schini VB; Scott-Burden T; Vanhoutte PM
Am J Physiol; 1992 Jun; 262(6 Pt 2):H1788-95. PubMed ID: 1621837
[TBL] [Abstract][Full Text] [Related]
32. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery.
Plane F; Wiley KE; Jeremy JY; Cohen RA; Garland CJ
Br J Pharmacol; 1998 Apr; 123(7):1351-8. PubMed ID: 9579730
[TBL] [Abstract][Full Text] [Related]
33. Enhanced production of nitric oxide in aortae from spontaneously hypertensive rats by interleukin-1 beta.
Junquero DC; Schini VB; Scott-Burden T; Vanhoutte PM
Am J Hypertens; 1993 Jul; 6(7 Pt 1):602-10. PubMed ID: 8398001
[TBL] [Abstract][Full Text] [Related]
34. Vascular smooth muscle influences the release of endothelium-derived relaxing factor.
Warren JB; Brady AJ; Taylor GW
Proc Biol Sci; 1990 Aug; 241(1301):127-31. PubMed ID: 1978339
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
[TBL] [Abstract][Full Text] [Related]
36. Role of intracellular Ca2+ in EDRF release in rat aorta.
Zheng XF; Kwan CY; Daniel EE
J Vasc Res; 1994; 31(1):18-24. PubMed ID: 8274622
[TBL] [Abstract][Full Text] [Related]
37. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.
Keaney JF; Simon DI; Stamler JS; Jaraki O; Scharfstein J; Vita JA; Loscalzo J
J Clin Invest; 1993 Apr; 91(4):1582-9. PubMed ID: 8473501
[TBL] [Abstract][Full Text] [Related]
38. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
[TBL] [Abstract][Full Text] [Related]
39. Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta.
Umans JG; Wylam ME; Samsel RW; Edwards J; Schumacker PT
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1638-45. PubMed ID: 8256913
[TBL] [Abstract][Full Text] [Related]
40. Low dose of lipopolysaccharide induces a delayed enhanced nitric oxide-mediated relaxation in rat aorta.
Pu Q; Bordet R; Robin E; Puisieux F; Vallet B; Dupuis B
Eur J Pharmacol; 1999 Jul; 377(2-3):209-14. PubMed ID: 10456432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
